"USA Children's and Women's Hospital is dedicated to the health care needs of children and women. Therapeutic and surgical services include traumatic injury, premature birth or high-risk OB/GYN needs."

During the past decade, University of South Alabama Children's and Women's Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of South Alabama Children's and Women's Hospital" #1 sponsor was "Abbott Nutrition" with 2 trials, followed by "Global Blood Therapeutics" with 2 trials sponsored, "GlycoMimetics Incorporated" with 2 trials sponsored, "Shire" with 2 trials sponsored and "Sucampo Pharma Americas, LLC" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of South Alabama Children's and Women's Hospital" #1 collaborator was "Sucampo AG" with 1 trials as a collaborator and "Takeda" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "University of South Alabama Children's and Women's Hospital" are "Retinopathy of Prematurity (ROP)" (3 trials), "Sickle Cell Disease" (3 trials), "Vaso-occlusive Crisis" (3 trials), "Constipation - Functional" (2 trials) and "Vaso-occlusive Pain Episode in Sickle Cell Disease" (2 trials). Many other conditions were trialed in "University of South Alabama Children's and Women's Hospital" in a lesser frequency.

Most popular intervention types in "University of South Alabama Children's and Women's Hospital" are "Drug" (10 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Inclacumab" (2 trials), "Lubiprostone" (2 trials), "Rivipansel" (2 trials) and "Human Milk Fortifier A" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of South Alabama Children's and Women's Hospital" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of South Alabama Children's and Women's Hospital". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in University of South Alabama Children's and Women's Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of South Alabama Children's and Women's Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".